British pharmaceutical giant AstraZeneca has announced that it will acquire American pharmaceutical company Alexion Pharmaceuticals.
The total acquisition price is about 4 trillion yen, and we want to increase our presence in the field of immunology.
AstraZeneca announced on the 12th that it will acquire Alexion of the United States.
The total purchase price is 39 billion dollars, about 4 trillion yen in Japanese yen, and the procedure will be completed from July to September next year.
AstraZeneca aims to strengthen its management base by acquiring Alexion, which has strengths in the development of therapeutic agents for rare diseases. It can enhance the feeling. "
AstraZeneca is developing a vaccine for the new coronavirus in collaboration with Oxford University in the United Kingdom, and Japan has officially signed a contract to receive the vaccine from January next year if the development is successful.